NOVN.SW vs. RHHBY
Compare and contrast key facts about Novartis AG (NOVN.SW) and Roche Holding AG (RHHBY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOVN.SW or RHHBY.
Key characteristics
| NOVN.SW | RHHBY | |
|---|---|---|
| YTD Return | 20.01% | 12.53% |
| 1Y Return | 17.79% | 12.84% |
| 3Y Return (Ann) | 14.13% | -2.44% |
| 5Y Return (Ann) | 7.92% | 6.03% |
| 10Y Return (Ann) | 7.20% | 3.82% |
| Sharpe Ratio | 1.19 | 0.61 |
| Daily Std Dev | 16.45% | 22.47% |
| Max Drawdown | -42.25% | -50.12% |
| Current Drawdown | -4.42% | -20.88% |
Fundamentals
| NOVN.SW | RHHBY | |
|---|---|---|
| Market Cap | CHF 198.73B | $251.45B |
| EPS | CHF 4.14 | $1.94 |
| PE Ratio | 23.71 | 20.16 |
| PEG Ratio | 4.17 | 1.23 |
Correlation
The correlation between NOVN.SW and RHHBY is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NOVN.SW vs. RHHBY - Performance Comparison
In the year-to-date period, NOVN.SW achieves a 20.01% return, which is significantly higher than RHHBY's 12.53% return. Over the past 10 years, NOVN.SW has outperformed RHHBY with an annualized return of 7.20%, while RHHBY has yielded a comparatively lower 3.82% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOVN.SW vs. RHHBY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and Roche Holding AG (RHHBY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOVN.SW vs. RHHBY - Dividend Comparison
NOVN.SW's dividend yield for the trailing twelve months is around 3.36%, less than RHHBY's 3.56% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVN.SW Novartis AG | 3.36% | 3.77% | 3.91% | 3.94% | 3.72% | 3.27% | 3.98% | 3.98% | 4.35% | 3.58% | 3.17% | 3.86% |
RHHBY Roche Holding AG | 3.56% | 3.55% | 3.23% | 2.47% | 2.63% | 2.69% | 3.58% | 3.22% | 3.62% | 3.14% | 3.23% | 2.88% |
Drawdowns
NOVN.SW vs. RHHBY - Drawdown Comparison
The maximum NOVN.SW drawdown since its inception was -42.25%, smaller than the maximum RHHBY drawdown of -50.12%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and RHHBY. For additional features, visit the drawdowns tool.
Volatility
NOVN.SW vs. RHHBY - Volatility Comparison
The current volatility for Novartis AG (NOVN.SW) is 4.11%, while Roche Holding AG (RHHBY) has a volatility of 9.20%. This indicates that NOVN.SW experiences smaller price fluctuations and is considered to be less risky than RHHBY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NOVN.SW vs. RHHBY - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Roche Holding AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities